Navigation Links
Exempla Healthcare Contracts For Talisman's Quality Donor System
Date:9/4/2007

VIENNA, Va., Sept. 4 /PRNewswire/ -- Talisman Ltd., the biomedical research group and developer of the Quality Donor System(TM) (QDS) is pleased to announce that Exempla Healthcare has contracted to utilize QDS, internet Quality Donor System(TM) (iQDS) and the Talisman Phlebotomy System(TM) (TPS).

QDS automates the gap between donor registration and the processing and testing of the blood. It utilizes audio-visual touch screen computer assisted donor self interviewing with the AABB Uniform Donor History Questionnaire and provides staff review with AABB and custom materials. QDS includes standardized but modifiable staff comments, vital signs data and donor and staff signature capture. iQDS allows their blood donors to respond to the Health History Questions On Line in the privacy and convenience of their home or office. TPS captures vital blood draw information and is operated by phlebotomists using wireless hand-held computers.

QDS is available in English and Spanish. The system runs in standalone and network modes, can export data, requires only a CBE-30 notification, necessitates only two to three hours of staff training and none for donors, and can be updated by Talisman with new FDA required questions in less than one week.

Six community blood centers and two medical centers with blood programs currently use QDS. To date, these centers have successfully completed more than 1,500,000 donor self-interviews using QDS. Earlier versions of the Talisman system have been scientifically proven to reduce FDA reportable errors by over 60%, improve reporting of risky donor behavior by up to a factor of 9, reduce staff time by 5 minutes per donor and vastly increase donor and staff satisfaction. The current version of QDS is expected to reduce FDA reportable errors by over 90%. The latest version of QDS, recently 510(k) cleared is expected to reduce errors still further and improve donor and sponsor satisfaction, i.e., the Internet donor or iQDS.'/>"/>

SOURCE Talisman Ltd.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Health Minister Ramadoss Honoured for his Exemplary Work
2. Prime Minister Lauds the Exemplary Work of Mumbai’s Medical Fraternit
3. SNM recognizes exemplary contributors in nuclear medicine
4. American Cancer Society Honors Exemplary Cancer Caregivers
5. Healthcare sector is now a multi billion-dollar industry in India
6. Iodex goes to SmithKline Beecham consumer Healthcare
7. Healthcare Professionals Might Want To Rethink Their Dress Code
8. WHO report asks for improved healthcare for mother and child
9. New X-ray machine launched by GE Healthcare
10. India To March Ahead in The Global HealthCare Competition
11. Medical Fraternity Urged To Revamp Indian Healthcare
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/28/2015)... 28, 2015 In recent years Medical Marijuana ... practicing physicians as a way for them to expand their ... Cannabis as medicine. Since the FDA still lists Cannabis as ... available to licensed physicians that can help guide them ... Deborah Malka in Santa Cruz, CA is a leader ...
(Date:2/28/2015)... OR (PRWEB) February 28, 2015 In ... Duncan Fletcher of Game Change Athlete ... Shannon Leinert about the benefits of athlete development and ... some of the unique challenges that athletes face and ... and future success. , Fletcher became involved in athlete ...
(Date:2/28/2015)... February 28, 2015 With their commitment ... has added an additional exercise to their already robust ... exercise is most commonly known as, is often performed ... Pulls” are executed in a relatively safe manner and ... strength levels. The full description of “Rope Pulls” is ...
(Date:2/28/2015)... (PRWEB) February 28, 2015 The ... is offering a new special. Throughout all of ... , This service can help ... problems and pain. Patients may notice certain symptoms that ... relining. These symptoms include: , 1.    Pain, clicking, and ...
(Date:2/28/2015)... Mew and Company, a Vancouver corporate tax ... business consulting services in addition to a variety of ... succession planning. Company finances are a complicated matter that ... of this, complex Canadian tax laws can make it ... result, Mew and Company works to advise their clients ...
Breaking Medicine News(10 mins):Health News:Reputable Cannabis Doctor In Santa Cruz and Monterey Joins the Medical Cannabis Network 2Health News:SCI TV Covers Athlete Development with Duncan Fletcher 2Health News:SCI TV Covers Athlete Development with Duncan Fletcher 3Health News:Classic Denture Center in Portland Oregon is Offering March Discount 2Health News:Vancouver Corporate Tax Accountants Now Provide Business Consulting Services 2
... , WEDNESDAY, Oct. 27 (HealthDay News) -- With ... expert offers breast cancer survivors some guidance on what ... Karen Syrjala, director of biobehavioral sciences and co-director ... Research Center in Seattle, touches upon both the lingering ...
... The brain,s inner network becomes increasingly more efficient as ... measures, a joint study from the Ecole Polytechnique Fdrale ... in collaboration with Harvard Medical School, has verified these ... the PNAS early online edition last week, the soon-to-be-released ...
... genes respond to hormonal changes and inflammation has been ... a five-year study. The research programme at the ... (BRC) is led by Professor Julian Davis, a consultant ... University of Manchester,s Developmental Biomedicine Research Group. He ...
... , TUESDAY, Oct. 26 (HealthDay News) --Middle-aged adults ... as a result of radiation exposure as younger adults ... thought to be more sensitive to the long-term impact ... runs counter to some previous research suggesting that as ...
... Institute in Melbourne, Australia, has been awarded a Victorian Cancer ... and highly lethal form of ovarian cancer. Epithelial ovarian ... the ovary, accounts for 90 per cent of ovarian tumours. ... research has revealed that it may start in cells outside ...
... though the cancer-treatment agent cetuximab is not considered effective ... research indicates that patients with colorectal cancer not responding ... who were treated with cetuximab had longer overall and ... a study in the October 27 issue of ...
Cached Medicine News:Health News:Women Urged to Reclaim Their Life After Breast Cancer 2Health News:The brain's journey from early Internet to modern-day fiber optics -- all in 1 lifetime 2Health News:Manchester team wins $1.9 million grant for 'cell control' study 2Health News:Cancer Risk From Radiation Doesn't Fade With Age 2Health News:VCA fellowship funding to extend ovarian cancer research 2Health News:Colorectal cancer patients with gene mutation show better response to cancer agent 2
(Date:2/27/2015)... 2015  Acsis Inc., the market leader for supply ... that John DiPalo , Acsis, Chief Strategy Officer, ... Chain Executive 2015 Provider Pro to Know. The ... to help prepare their companies, and customers, supply chains ... year,s list of Provider Pros to Know is featured ...
(Date:2/27/2015)... Feb. 27, 2015 Isis Pharmaceuticals, Inc. (Nasdaq: ... both its pro forma net operating loss (NOL) guidance ... strong financial position.  Isis, significantly improved financial results were ... million in payments the Company received from its partners.  ... was a nearly 60% improvement over its 2013 NOL ...
(Date:2/27/2015)... February 27, 2015 Report Details ... showing you trends, R&D progress, and predicted revenues ,Where ... What are the commercial prospects for this market and ... revenues and other trends to 2025, discussing data, opportunities ... you assess regenerative medicine : cell-based therapies that ...
Breaking Medicine Technology:Acsis CSO John DiPalo Named Supply & Demand Chain Executive 2015 Pro to Know 2Isis Reports Financial Results and Highlights for 2014 2Isis Reports Financial Results and Highlights for 2014 3Isis Reports Financial Results and Highlights for 2014 4Isis Reports Financial Results and Highlights for 2014 5Isis Reports Financial Results and Highlights for 2014 6Isis Reports Financial Results and Highlights for 2014 7Isis Reports Financial Results and Highlights for 2014 8Isis Reports Financial Results and Highlights for 2014 9Isis Reports Financial Results and Highlights for 2014 10Isis Reports Financial Results and Highlights for 2014 11Isis Reports Financial Results and Highlights for 2014 12Isis Reports Financial Results and Highlights for 2014 13Isis Reports Financial Results and Highlights for 2014 14Isis Reports Financial Results and Highlights for 2014 15Isis Reports Financial Results and Highlights for 2014 16Isis Reports Financial Results and Highlights for 2014 17Translational Regenerative Medicine: Market Prospects 2015-2025 2Translational Regenerative Medicine: Market Prospects 2015-2025 3Translational Regenerative Medicine: Market Prospects 2015-2025 4Translational Regenerative Medicine: Market Prospects 2015-2025 5Translational Regenerative Medicine: Market Prospects 2015-2025 6Translational Regenerative Medicine: Market Prospects 2015-2025 7Translational Regenerative Medicine: Market Prospects 2015-2025 8
... 2012  Boehringer Ingelheim will present results from LUX-Lung ... investigating afatinib in patients with stage IIIB or ... epidermal growth factor receptor (EGFR) mutation (EGFR M+), ... Society of Clinical Oncology (ASCO) in Chicago, June ...
... May 16, 2012  Leading events organiser UBM Conferences ... announced details of the forthcoming CPhI Extractables and Leachables ... 2pm IST/9:30am GMT/4:30pm CST. The free to attend webinar ... extractables and leachables and during drug development, in addition ...
Cached Medicine Technology:Boehringer Ingelheim to present pivotal Phase III results for afatinib in first-line treatment of EGFR mutation-positive NSCLC at ASCO 2012 2Boehringer Ingelheim to present pivotal Phase III results for afatinib in first-line treatment of EGFR mutation-positive NSCLC at ASCO 2012 3Boehringer Ingelheim to present pivotal Phase III results for afatinib in first-line treatment of EGFR mutation-positive NSCLC at ASCO 2012 4Boehringer Ingelheim to present pivotal Phase III results for afatinib in first-line treatment of EGFR mutation-positive NSCLC at ASCO 2012 5Boehringer Ingelheim to present pivotal Phase III results for afatinib in first-line treatment of EGFR mutation-positive NSCLC at ASCO 2012 6Boehringer Ingelheim to present pivotal Phase III results for afatinib in first-line treatment of EGFR mutation-positive NSCLC at ASCO 2012 7Global Webinar Focuses on Considerations for Extractables and Leachables 2
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: